Stock screenerAll disclosures →
EDGAR →
BBNX
Conviction 63HealthcareScan · Thu, Sep 24, 2026Beta Bionics, Inc. (BBNX) closed at $21.76 (-1.96%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 61, RS Rating 93, -32.0% from its 52-week high, -25.6% year to date. Sector: Healthcare · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
BBNX$21.76-1.96%
ResistanceSupportVol 14Insider sell2
Vol MA14 1.75M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price21.76
Change-1.96%
Gap+0.88%
Rel volume0.77×
Avg volume1.45M
Avg $ vol29.71M
SMA 2019.86
SMA 5018.03
SMA 20016.10
Price vs 50+20.65%
Price vs 200+35.09%
MA stackbullish
50/200 cross—
Supertrendup · 18.12
RSI (14)61
MACD hist0.27
MACD crossbull · 5d
Stoch %K / %D78 / 84
ADX (14)34
+DI / −DI31 / 13
RSI divergence—
MACD divergenceBearish
ATR %6.80%
ADR %7.38%
52w high31.99
52w low8.86
From 52w high-31.99%
Above 52w low+145.54%
New 52w highNo
SqueezeOff
Bollinger width38.62%
%B0.75
Donchian pos77.58%
Donchian high23.56
Donchian low15.51
AVWAP (52w high)16.65
vs AVWAP high+30.63%
AVWAP (52w low)15.52
vs AVWAP low+40.13%
OBV trendUp
Chaikin MF (20)0.29
Today vs 20d0.77×
Avg vol (14d)1.75M
Avg vol (20d)1.45M
Avg $ vol (20d)29.71M
Market cap978.75M
RS Rating93 / 99
RS 3m (vs SPY)+32.25%
RS 6m (vs SPY)+75.53%
RS line new highNo
Trend template4/8
Technical rank93.1
1 week+1.52%
1 month+12.49%
3 months+36.74%
6 months+92.35%
1 year-4.88%
YTD-25.62%
P/E-13.37
P/B3.82
P/S9.76
P/FCF-17.41
EPS-1.81
Div yield—
ROE-28.55%
ROA-25.04%
Debt/Eq—
Current8.88
EV/EBITDA—
Gross margin55.40%
Net margin-73.02%
Rev growth53.94%
EPS growth-33.68%
Price target23.20
Target upside6.64%
Analyst ratingBuy
Institutional95.89%
Ent. value934.43M
Revenue32.01M
Net income-23.4M
Gross profit18.9M
Free cash flow-56.22M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out44.56M
Employees423
ListedThu, Jan 30, 2025
Free float37.66M
Float %84.8%
Short interest9.4M
Days to cover9.0d
Short volume73.3%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.53 vs −$0.62
Last surprise+14.5% beat
Setup gradeB
Conviction63 / 100
Pattern quality—
Tech rank93.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance23.11
Support14.12
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365Yahoo Finance · Tue, Sep 22, 2026
Congress activity
Disclosed STOCK Act trades in BBNX
No recent disclosed trades by Congress in BBNX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BBNX · open-market 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Jones Christy Director · Common Stock · 2026-09-22 | Sell | 6.43K | $148K | 2026-09-22 | 2026-09-23 |
Hopman Mark Chief Commercial Officer · Common Stock · 2026-09-16 | Sell | 30.78K | $620K | 2026-09-16 | 2026-09-17 |
Mensinger Mike Chief Product Officer · Common Stock · 2026-09-16 | Sell | 2.65K | $58K | 2026-09-16 | 2026-09-17 |
Hopman Mark Chief Commercial Officer · Common Stock · 2026-09-14 | Sell | 775 | $12K | 2026-09-14 | 2026-09-15 |
Feider Stephen Chief Financial Officer · Common Stock · 2026-06-29 | Sell | 4.9K | $83K | 2026-06-29 | 2026-06-30 |
Feider Stephen Chief Financial Officer · Common Stock · 2026-06-29 | Exercise | 4.9K | $25K | 2026-06-29 | 2026-06-30 |
Feider Stephen Chief Financial Officer · Employee Stock Option (right to buy) · 2026-06-29 | Exercise | 4.9K | — | 2026-06-29 | 2026-06-30 |
Feider Stephen Chief Financial Officer · Common Stock · 2026-06-26 | Exercise | 4.98K | $25K | 2026-06-26 | 2026-06-30 |
Feider Stephen Chief Financial Officer · Employee Stock Option (right to buy) · 2026-06-26 | Exercise | 4.98K | — | 2026-06-26 | 2026-06-30 |
Feider Stephen Chief Financial Officer · Common Stock · 2026-06-26 | Sell | 5.1K | $87K | 2026-06-26 | 2026-06-30 |
SEC filings
EDGAR filings in BBNX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.